Berlin, Germany, February 1 -- Leukemia patients undergoing blood stem cell transplants tend to live almost equal to patients having bone marrow transplants, reveals a new study.
The study carried out at Charite Medicine University found that leukemia patients undergoing peripheral blood stem cell transplantation (PBSCT), have just about a similar survival rate to their counterparts undergoing bone marrow transplant, depending on variety of patients.
“But patients with acute forms of blood cancer appear to do better if they have bone marrow as opposed to blood stem cell transplants,” said the study authors.
They also suggested that, “For some the benefit of the complex treatment is greater in the long run.”
Details of the study
